Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-04-24
著者
-
小林 智
協和発酵工業株式会社 医薬開発本部非臨床開発部
-
KOBAYASHI Satoshi
Drug Development Research Laboratories, Pharmaceutical Research, Institute, Kyowa Hakko Kogyo Co., L
-
Tanii Hiromi
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
KOBAYASHI Hiroyuki
Drug Development Research Laboratories, Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Lt
-
Kurata Noriaki
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Kuwabara Takashi
Pharmacokinetic Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Katagiri S
Faculty Of Engineering Niigata University
-
Kuwabara Takashi
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd
-
FUSE Eiichi
Drug Development Research Laboratories, Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Lt
-
KURAMITSU Tomoko
Drug Development Research Laboratories, Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Lt
-
Fuse Eiichi
Pharmacokinetic Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Fuse Eiichi
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd
-
Kobayashi Satoshi
Analytical And Pharmacokinetic Department Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co.
-
Kobayashi Satoshi
Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Kuramitsu Tomoko
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Kobayashi Hiroyuki
Pharmacokinetic Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
Kobayashi Satoshi
Analytical & Pharmacokinetic Laboratories Pharmaceutical Research Institute Kyowa Hakko Hagyo Co
-
Kobayashi Satoshi
Drug Development Research Laboratories Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
関連論文
- ヒト顆粒球コロニー形成刺激因子 (hG-CSF) 誘導体 Nartograstim の代謝
- 顆粒球コロニー形成刺激因子(G-CSF)のファーマコキネティクス - 体内動態における受容体介在性クリアランスの寄与 -
- 新規抗アレルギー薬KW-4679の体内動態(第6報):各種実験動物における血漿中動態
- 消化管機能亢進薬KW-5139のクリアランス機構
- Synthesis of a Dibenz[b, e]oxepin-Bovine Serum Albumin Conjugate for Radioimmunoassay of KW-4679 ((Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b, e]oxepin-2-acetic Acid Hydrochloride)
- 酵素阻害に起因する薬物相互作用のインビトロ評価 - HABプロトコール -
- 塩酸ベニジピンの高血圧自然発症ラットの血圧・心拍数および血漿中ノルエピネフリン濃度に及ぼす影響
- Crystal Structure and Optical Properties of Defect-Chalcopyrite-Type MnGa_2S_4
- New Approach for Measurement of Sympathetic Nervous Abnormality in Conscious, Spontaneously Hypertensive Rats
- 新規抗アレルギー薬KW-4679の体内動態(第5報):^C-KW-4679のラットにおける胎児移行性および乳汁移行性
- 新規抗アレルギー薬KW-4679の体内動態(第4報):KW-4679のラットおよびイヌにおける代謝
- 新規抗アレルギー薬KW-4679の体内動態(第3報):^C-KW-4679のイヌにおける経口投与後の吸収および排泄
- 新規抗アレルギー薬KW-4679の体内動態(第2報):^C-KW-4679のラットに反復経口投与時の吸収, 排泄, 分布および薬物代謝酵素系に及ぼす影響
- 新規抗アレルギー薬KW-4679の体内動態(第1報):^C-KW-4679のラットにおける単回投与時の吸収, 分布および排泄
- 13P-7-34 Erdosteine および光学活性代謝物の HPLC 蛍光分析
- 新規免疫抑制剤KF20444の作用機構(1) : ピリミジンde novo生合成阻害作用
- 2005年薬物動態学会ワークショップの企画主旨について
- 薬物動態研究による創薬の推進(PK/PDアプローチ)
- REVIEW : New Drug and Recent Technique : Pharmacological, Pharmacokinetic and Clinical Properties of Olopatadine Hydrochloride, a New Antiallergic Drug
- Comparison of the Antidiarrheal Effects of Zaldaride Maleate and Its Optical Isomers in Rats
- Gender Differences in the Antidiarrheal Effect of Zaldaride Maleate in Rats
- Antidiarrheal Effects of Zaldaride Maleate After Oral, Intravenous and Subcutaneous Administration to Rats
- Optical Properties of Ag (Al_xGa_)S_2 Epitaxial Layers Grown on GaAs (100) by Multisource Evaporation
- Preparation and Properties of Ag(Al_xGa_)S_2 Crystals by Iodine Transport Method
- Effect of Lattice Strain on Exciton Energy of AgGaS_2 Epitaxial Layers on GaAs (100)
- Lattice Strain in AgGaS_2 Epitaxial Layers Grown on GaAs (100) by Multisource Evaporation
- Dependence of Energy Gap on x in CuAl_xGa_S_2 Mixed Crystal System : Semiconductors and Semiconductor Devices
- Absorption Edge Studies of CuGaS_2 Single Crystal
- DC Green Electroluminescence of Al-CuGaS_2 Diode
- Green Eleclroluminescence from ZnS-CuGaS_2 Heterojunction Diode in DC Operation
- Highly Sensitive Enzyme-Linked Immunosorbent Assay for Marograstim (KW-2228), a Mutant of Human Granulocyte Colony-Stimulating Factor
- Characterization of a Binding Site of UCN-01,a Novel Anticancer Drug on α_1-Acid Glycoprotein
- Effect of Pregnancy on the Disposition of Valproate in Rats
- IL-2 Perfusion to the Liver Augments the Hepatic Extraction Rate of Accompanying Anticancer Drugs
- ◆◆フォーラム 1999◆◆薬物間相互作用ワーキンググループ活動について : 日本製薬工業協会医薬品評価部会基礎研究部会第4分科会
- Identification of the Major Degradation Products of Vinorelbine by Frit-FABLC/MS and NMR
- Development of a sensitive liquid chromatography-electrospray ionization tandem mass spectrometry method for measurement of 7-cyanoquinocarcinol in human plasma
- Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine
- The Contribution of Cytochrome P450 to the Metabolism of Tegafur in Human Liver
- High-performance liquid chromatographic determination of erdosteine and its optical active metabolite utilizing a fluorescent chiral tagging reagent, R-(-)-4-(N,N-dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole
- 高速液体クロマトグラフィ-による生体試料中フルナリジンの定量